MarketPulse

securities fraud

1939 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

ATRA Hit With Securities Fraud Suit Over Manufacturing Issues, Regulatory Misstatements

Atara Biotherapeutics faces securities fraud class action for allegedly misrepresenting manufacturing capabilities and overstating regulatory prospects for tabelecleucel between May 2024 and January 2026.
CWHINOATRAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Aquestive Therapeutics Faces Securities Fraud Lawsuit After 37% Stock Plunge

Aquestive Therapeutics faces securities fraud lawsuit after 37% stock drop tied to undisclosed FDA deficiencies in Anaphylm NDA. Lead plaintiff recruitment deadline: May 4, 2026.
AQSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Gartner Hit With Securities Fraud Suit Over Concealed CV Growth Collapse

Law firm Levi & Korsinsky files class action against $GTN, alleging management concealed contract value growth deterioration from 7% to 1%, causing 52% stock decline.
ITsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Grocery Outlet Stock Crashes 28% as Securities Fraud Lawsuit Targets CEO Over Misleading Expansion Claims

Grocery Outlet faces securities lawsuit alleging CEO and CFO certified false statements about store expansion and profitability, triggering 27.9% stock plunge.
GOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

PSIX Plummets 47% as Securities Lawsuit Alleges Margin Concealment Fraud

Power Solutions International faces class action over allegedly concealing margin deterioration from May 2025-March 2026, with stock cratering 47% post-disclosure.
PSIXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

NUAI Faces Class Action Over Data Center Claims and Oil Well Remediation Fraud

Robbins LLP filed class action against $NUAI alleging misleading investor statements on Texas data centers and New Mexico oil well scheme. Lead plaintiff deadline: June 1, 2026.
NUAINUAIWsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Class Action Lawsuit Targets REGENXBIO Over RGX-111 Gene Therapy Disclosures

Investors in $REGENXBIO face class action lawsuit alleging false statements about RGX-111 gene therapy development and clinical trial results spanning 2022-2026.
RGNXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Class Action Alleges Atara Biotherapeutics Concealed Manufacturing and Trial Defects

Class action lawsuit filed against Atara Biotherapeutics for allegedly misrepresenting manufacturing issues and ALLELE study deficiencies affecting tabelecleucel approval prospects.
ATRAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Gemini Space Station Hit With Securities Fraud Class Action Over Crypto Platform Claims

Class action lawsuit filed against $GEMI alleging securities fraud over overstated crypto platform viability and expansion prospects during IPO period.
GEMIsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

NuScale Faces Class Action Over ENTRA1 Partnership Claims

Class action lawsuit filed against NuScale Power alleging false statements about partner ENTRA1's nuclear experience, claiming hundreds of millions at risk.
SMRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Soleno Therapeutics Hit With Securities Fraud Class Action Over Undisclosed Drug Safety Issues

Soleno Therapeutics faces class action lawsuit alleging failure to disclose material DCCR drug safety concerns, including excess fluid retention in clinical trials that reduced commercial viability.
SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Ostin Technology Hit With $950M Fraud Lawsuit Over Alleged Pump-and-Dump Scheme

Class action filed against Ostin Technology ($OST) alleging pump-and-dump fraud, with estimated investor losses exceeding $950 million from May-June 2025 trading period.
OSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Aquestive Therapeutics Hit With Securities Fraud Suit Over Anaphylm FDA Timeline Claims

Class action lawsuit filed against Aquestive Therapeutics alleging securities fraud related to Anaphylm FDA approval timeline and undisclosed human factors risks.
AQSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Schall Law Firm

Navan IPO Under Fire: Class Action Alleges Material Omissions on Growth Spending

Schall Law Firm files securities fraud lawsuit against $NAVN over alleged misstatements during October 2025 IPO, claiming undisclosed post-IPO spending needs.
NAVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Oracle Faces Class Action Over AI Strategy Disclosures; Investors Urged to Join Suit

Class action lawsuit filed against $ORCL alleges false AI strategy statements, concealed risks to debt, credit rating, and cash flow. Lead plaintiff deadline April 6, 2026.
ORCLORCLpDsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Ultragenyx Faces Class Action Over Failed Drug Trials; April 6 Lead Plaintiff Deadline Looms

Ultragenyx faces class action lawsuit over misleading statements on setrusumab efficacy. Stock crashed 42% after Phase III trials failed. Lead plaintiff deadline: April 6, 2026.
RAREsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Schall Law Firm

Kyndryl Faces Securities Fraud Class Action Over Accounting, Control Failures

Kyndryl faces class action lawsuit alleging securities fraud, false statements, and control failures. Investors who purchased stock August 2024-February 2026 may be eligible.
KDsecurities fraudclass action lawsuit
BenzingaBenzinga··The Schall Law Firm

Coty Faces Class Action Over Growth Claims as Beauty Segment Struggles

Schall Law Firm seeks Coty Inc. shareholders for securities fraud class action alleging false growth statements while Consumer Beauty segment underperformed and margins eroded.
COTYsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Xponential Fitness Faces Securities Fraud Investigation After 39% Stock Plunge

Law firm investigates Xponential Fitness for alleged securities fraud following 39% stock drop on June 27, 2023, citing misrepresented financial health and store closure claims.
XPOFsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Galaxy Digital Under Securities Fraud Investigation After $482M Loss Triggers 17% Plunge

Portnoy Law Firm launches securities fraud probe into $GLXY after 16.87% stock drop following disclosure of $482M Q4 2025 net loss.
GLXYsecurities fraudinvestor losses